Resistance to quinolones in mycobacteria

Research in Microbiology

Volumn 147, Issue 1-2, 1996, Pages 52-59

  Cambau, E ^a   Jarlier, V ^a  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CAPREOMYCIN; CYCLOSERINE; ISONIAZID; KANAMYCIN; OFLOXACIN; PEFLOXACIN; QUINOLONE; THIOACETAZONE;

ANTIBIOTIC RESISTANCE; BACTERIUM MUTANT; CONFERENCE PAPER; DRUG ACTIVITY; DRUG EFFICACY; HUMAN; MYCOBACTERIOSIS; MYCOBACTERIUM TUBERCULOSIS; PRIORITY JOURNAL; TUBERCULOSIS;

EID: 0029920518     PISSN: 09232508     EISSN: None     Source Type: Journal    
DOI: 10.1016/0923-2508(96)80204-X     Document Type: Conference Paper

References (41)

1. Alangaden, G.J., Manavathu, E.K., Vakulenko, S.B., Zvonok, N.M. & Lerner, S.A. (1995), Characterization of fluoroquinolone-resistant mutant strains of Mycobacterium tuberculosis selected in the laboratory and isolated from patients. Antimicrob. Agents Chemother., 39, 1700-1703.
2. Benson, C.A. (1994), Treatment of disseminated disease due to the Mycobacterium avium complex in patients with AIDS. Clin. Infect. Dis., 18 (suppl. 3), 237-242.
3. Cambau, E. & Gutmann, L. (1993), Mechanisms of resistance to quinolones, in "Proceedings of the fourth symposium on quinolones (Munich)". Drugs, 45 (suppl. 3), 15-23.
4. Cambau, E., Sougakoff, W. & Jarlier, V. (1994a), Amplification and nucleotide sequence of the quinolone resistance-determining region in the gryA gene of mycobacteria. FEMS Microbiol. Lett., 116, 49-54.
5. Cambau, E., Sougakoff, W., Besson, M., Truffot-Pernot, C., Grosset, J. & Jarlier, V. (1994b), Selection of a gyrA mutant of Mycobacterium tuberculosis during treatment by ofloxacin. J. Infect. Dis., 170, 479-483.
6. Chan, G.P., Garcia-Ignacio, B.Y., Chavez, V.E., Livelo, J.B., Jimenez, C.L., Parilla, M.L.R. & Franzblau, S.G. (1994), Clinical trial of sparfloxacin for lepromatous leprosy. Antimicrob. Agents Chemother., 38, 61-65.
7. Decludt, B., Schwoebel, V., Haeghebaert, S., Vincent, V., Clément, F., Perronne, C. & Grosset, J. (1994), Surveillance de la tuberculose à bacilles multirésistants en 1993. Bulletin Epidémiologique Hebdomadaire, 50, 235-236.
8. Ferrero, L., Cameron, B., Manse, B., Lagneaux, D., Crouzet, J., Framechon, A. & Blanche, F. (1994), Cloning and primary structure of Staphylococcus aureus DNA topoisomerase. - IV. A primary target of fluoroquinolones. Mol. Microbiol., 13, 641-653.
9. Grosset, J.H., Ji, B., Guelpa-Lauras, C.C., Perani, E.G. & N'Deli, L.N. (1990), Clinical trial of pefloxacin and ofloxacin in the treatment of lepromatous leprosy. Int. J. Lepr., 58, 281-295.
10. Grosset, J., Guelpa-Lauras, C.C., Perani, E. & Beoletto, C. (1988), Activity of ofloxacin against Mycobacterium leprae in the mouse. Int. J. Lepr., 56, 259-264.
11. Guillemin, I., Cambau, E. & Jarlier, V. (1995a), Sequences of a conserved region in the A subunit of DNA gyrase from nine species of the genus Mycobacterium: phylogenetic analysis and implication for intrinsic susceptibility to quinolones. Antimicrob. Agents Chemother., 39, 2145-2149.
12. Guillemin, I., Cambau, E. & Jarlier, V. (1995b), Occurrence of gyrA mutations in in vitro fluoroquinolone-resistant mutants of Mycobacterium fortuitum, in "Program and abstracts of the 35th Interscience Conference on Antimicrobial Agents and Chemotherapy". American Society for Microbiology, Washington DC.
13. Haemers, A., Leysen, D.C., Bollaert, W., Zhang, M. & Pattyn, S.R. (1990), Influence of N-substitution of antimycobacterial activity of ciprofloxacin. Antimicrob. Agents Chemother., 34, 496-497.
14. Hong Kong Chest Service, British Medical Research Council. (1992), A controlled study of rifabutin and an uncontrolled study of ofloxacin in the retreatment of patients with pulmonary tuberculosis resistant to isoniazid, streptomycin and rifampicin. Tubercle Lung Dis., 73, 59-67.
15. Jarlier, V., & Nikaido, H. (1990), Permeability barrier toward hydrophilic solutes in Mycobacterium chelonei. J. Bacteriol., 172, 1418-1423.
16. Jarlier, V. & Nikaido, H. (1994), Mycobacterial cell wall: structure and role in natural resistance to antibiotics. FEMS Microbiol. Lett., 123, 11-18.
17. Ji, B., Truffot-Pernot, C. & Grosset, J. (1991), In vitro and in vivo activities of sparfloxacin against Mycobacterium tuberculosis. Tubercle, 72, 181-186.
18. Ji, B., Lounis, N., Truffot-Pernot, C. & Grosset, J. (1995), In vitro and in vivo activities of levofloxacin against Mycobacterium tuberculosis. Antimicrob. Agents Chemother., 39, 1341-1344.
19. Ji, B., Perani, E.G., Petinon, C., N'Deli, L. & Grosset, J.H. (1994), Clinical trial of ofloxacin alone and in combination with dapsone plus clofazimine for treatment of lepromatous leprosy. Antimicrob. Agents Chemother., 38, 662-667.
20. Levy, S.B. (1992), Active efflux mechanisms for antimicrobial resistance. Antimicrob. Agents Chemother., 36, 695-703.
21. Leysen, D.C., Haemers, A. & Pattyn, S.R. (1989), Mycobacteria and the new quinolones. Antimicrob. Agents Chemother., 33, 1-5.
22. Margerrison, E.E.C., Hopewell, R., Fisher, L.M. (1992), Nucleotide sequence of the Staphylococcus aureus gyrB-gyrA locus encoding the DNA gyrase A and B proteins. J. Bacteriol., 174, 1596-1603.
23. Moriya, S., Ogasawara, N. & Yoshikawa, H. (1985), Structure and function of the region of the replication origin of the Bacillus subtilis chromosome. III. Nucleotide sequence of some 10,000 base pairs in the origin region. Nucleic Acids Res., 13, 2251-2265.
24. Pretet, S., Lebeaut, A., Parrot, R., Truffot, C., Grosset, J., Dinh-Xuan, A.T. & G.E.T.I.M. (1992), Combined chemotherapy including rifabutin for rifampicin and isoniazid resistant pulmonary tuberculosis. Eur. Respir. J., 5, 680-684.
25. Rao, S. (1995), An uncontrolled trial of pefloxacin in the retreatment of patients with pulmonary tuberculosis. Tubercle Lung Dis., 76, 219-222.
26. Revel, V., Cambau, E., Jarlier, V. & Sougakoff, W. (1994), Characterization of mutations in Mycobacterium smegmatis involved in resistance to fluoroquinolones. Antimicrob. Agents Chemother., 38, 1991-1996.
27. Sreedharan, S., Oram, M., Jensen, B., Peterson, L.R. & Fisher, L.M. (1990), DNA gyrase gyrA mutations in ciprofloxacin-resistant strains of Staphylococcus aureus: close similarity with quinolone resistance mutations in Escherichia coli. J. Bacteriol., 172, 7260-7262.
28. Sullivan, E., Kreiswirth, B., Palumbo, L., Kapur, V., Musser, J.M., Ebrahimzadeh, A. & Frieden, T.R. (1995), Emergence of fluoroquinolone-resistant tuberculosis in New York City. Lancet, 345, 1148-1150.
29. Takiff, H.E., Salazar, L., Guerrero, C., Philipp, W., Huang, W.M., Kreiswirth, B., Cole S.T., Jacobs, W.R., Jr & Telenti, A. (1994), Cloning and nucleotide sequence of Mycobacterium tuberculosis gyrA and gyrB genes and detection of quinolone resistance mutations. Antimicrob. Agents Chemother., 38, 773-780.
30. Telenti, A., Imboden, P., Marchesi, F., Schmidheini, T. & Bodmer, T. (1993), Direct, automated detection of rifampin-resistant mutants of Mycobacterium tuberculosis by PCR and single-strand conformation polymorphism. Antimicrob. Agents Chemother., 37, 2054-2058.
31. Trias, J., Jarlier, V. & Benz, R. (1992), Porins in the cell wall of mycobacteria. Science, 258, 1479-1481.
32. Truffot-Pernot, C., Ji, B. & Grosset, J. (1991), Activities of pefloxacin and ofloxacin against mycobacteria: in vitro and mouse experiments. Tubercle, 11, 57-64.
33. Tsukamura, M. (1985), In vitro antituberculosis activity of a new antibacterial substance, ofloxacin (DL8280). Am. Rev. Respir. Dis., 131, 348-351.
34. Tsukamura, M., Nakamura, E., Yōshii, S. & Amano, H. (1985), Therapeutic effect of a new antibacterial substance, ofloxacin (DL8280), on pulmonary tuberculosis. Am. Rev. Respir. Dis., 131, 352-356.
35. Wallace, R.J. Jr, Bedsole, G., Sumter, G., Sanders, C.V., Steele, L.C., Brown, B.B., Smith, J. & Graham, D.R. (1990), Activities of ciprofloxacin and ofloxacin against rapidly growing mycobacteria with demonstration of acquired resistance following single-drug therapy. Antimicrob. Agents Chemother., 34, 65-70.
36. Wang, J. (1985), DNA topoisomerases. Annu. Rev. Biochem., 54, 665-697.
37. Willcox, P.A., Groenewald, P.J. & Mackenzie, C.R. (1993), Ofloxacin-based chemotherapy in multiply drug-resistant pulmonary tuberculosis. Drugs, 45 (suppl. 3), 223-224.
38. Willmott, C.J.R. & Maxwell, A. (1993), A single point mutation in the DNA gyrase A protein greatly reduces binding of fluoroquinolones to the gyrase-DNA complex. Antimicrob. Agents Chemother, 37, 126-127.
39. Wolfson, J.S. & Hooper, D.C. (1989), Fluoroquinolones, antimicrobial agents. Clin. Microbiol. Rev., 2, 378-424.
40. Yew, W.W., Kwan, S.Y.L., Ma, W.K., Lui, K.S. & Suen, H.C. (1990), Ofloxacin therapy of Mycobacterium fortuitum infection: further experience. J. Antimicrob. Chemother., 25, 880-881.
41. Yoshida, H., Bogaki, M., Nakamura, M. & Nakamura, S. (1990), Quinolone resistance-determining region in the DNA gyrase gyrA gene of Escherichia coli. Antimicrob. Agents Chemother., 34, 1271-1272.